• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

    3.010 -0.100 (-3.22%)
    Streaming Delayed Price Updated: 4:00 PM EDT, May 22, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 13,995,425
    Open 3.100
    Bid (Size) 3.020 (1,200)
    Ask (Size) 3.030 (7,200)
    Prev. Close 3.110
    Today's Range 2.980 - 3.170
    52wk Range 2.770 - 7.180
    Shares Outstanding 168,425,907
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    A Deep Dive Into NVIDIA’s Latest Portfolio Moves ↗
    NVIDIA's latest 13F filing does not tell the story it seems to at first glance. The apparent divergence in its CoreWeave and Nebius holdings is a prime example. 
    Via MarketBeat
    Topics Artificial Intelligence Economy Regulatory Compliance
    TechMediaBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Advances AI Voice-Based Intoxication Detection as Real-Time Diagnostics Market Expands
    Via Investor Brand Network
    Topics Artificial Intelligence

    Performance

    YTD
    -28.3%
    -28.3%
    1 Month
    -15.4%
    -15.4%
    3 Month
    -19.1%
    -19.1%
    6 Month
    -21.8%
    -21.8%
    1 Year
    -26.5%
    -26.5%

    More News

    Read More
    The Future of Intoxication Detection May Be in Your Voice
    Via Investor Brand Network
    Topics Artificial Intelligence
    Recursion Pharmaceuticals (RXRX) Q1 2026 Results: Revenue Miss Overshadows Narrower Net Loss ↗
    Via Chartmill
    Recursion Pharmaceuticals (NASDAQ:RXRX) Soars on Q4 Earnings Beat ↗
    Via Chartmill
    News headline image
    The Future of Intoxication Detection May Be in Your Voice
    From BioMedWire
    Via GlobeNewswire
    News headline image
    3 Stocks Poised to Disrupt the Healthcare Market by 2030 ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Recursion (RXRX) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Recursion Reports First Quarter Financial Results and Provides Business Update
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Recursion Announces Board Transition
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Recursion to Report First Quarter 2026 Business Updates and Financial Results on May 6
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Recursion to Participate in Upcoming Investor Conferences
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Lilly’s $47.8 Billion Bet: Why the Contessa Acquisition Redefines the Future of Medicine
    Via MarketMinute
    Topics Artificial Intelligence
    News headline image
    1 Beaten-Down AI Stock to Buy and 1 to Avoid ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform
    From Citeline
    Via GlobeNewswire
    News headline image
    2 AI Healthcare Stocks to Buy Right Now ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Recursion Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer
    From Recursion Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Prediction: The "Trough of Disillusionment" Will Create the Best Buying Opportunity for Artificial Intelligence (AI) Stocks in 2026 ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Want $1 Million in Retirement? Invest $10,000 in These 2 AI Stocks and Hold for 10 Years. ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Can This AI Stock Bounce Back in 2026? ↗
    Via The Motley Fool
    Topics Animal Testing Artificial Intelligence
    News headline image
    Stocks Under $5 to Watch Now: LRMR, RXRX, NDRA, BTQ, CDIO Watch Now!
    Via AB Newswire
    Topics Artificial Intelligence Intellectual Property
    News headline image
    Recursion (RXRX) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Artificial Intelligence Earnings
    News headline image
    What's Behind The Jump In Recursion Pharmaceuticals Stock? ↗
    Via Benzinga
    News headline image
    RXRX Stock Soars Pre-Market On Q4 Beat, Recursion CEO Says Company Has ‘Reached An Inflection Point’ ↗
    Via Stocktwits
    Topics Artificial Intelligence
    News headline image
    Recursion Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
    From Recursion Pharmaceuticals
    Via GlobeNewswire

    Frequently Asked Questions

    Is Recursion Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
    Yes, Recursion Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
    What exchange does Recursion Pharmaceuticals, Inc. - Class A Common Stock trade on?
    Recursion Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock?
    The ticker symbol for Recursion Pharmaceuticals, Inc. - Class A Common Stock is RXRX on the Nasdaq Stock Market
    What is the current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
    The current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 3.010
    When was Recursion Pharmaceuticals, Inc. - Class A Common Stock last traded?
    The last trade of Recursion Pharmaceuticals, Inc. - Class A Common Stock was at 05/22/26 04:00 PM ET
    What is the market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
    The market capitalization of Recursion Pharmaceuticals, Inc. - Class A Common Stock is 506.96M
    How many shares of Recursion Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
    Recursion Pharmaceuticals, Inc. - Class A Common Stock has 507M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.